Skip to main content

Adjuvant capecitabine adds no advantage to bisphosphonate in elderly breast cancer patients

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Adjuvant capecitabine adds no advantage to bisphosphonate in elderly breast cancer patients

User login

Username

Password

Reset your password

Type	Lead	score